Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.
Seliger B, Menig M, Lichtenfels R, Atkins D, Bukur J, Halder TM, Kersten M, Harder A, Ackermann A, Beck J, Muehlenweg B, Brenner W, Melchior S, Kellner R, Lottspeich F.
Seliger B, et al.
Proteomics. 2003 Jun;3(6):979-90. doi: 10.1002/pmic.200300404.
Proteomics. 2003.
PMID: 12833523